This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. The multidisciplinary panel will discuss the aspects of getting a team of APP, Optometrist, and Gynecologic Oncologist educated and prepared for giving Mirvetuximab soravtansine. The session wraps up with some key take home points on Mirvetuximab soravtansine.  2022-2023 SGO Chemotherapy/Targeted Therapies Subcommittee Members and Moderators:Tracilyn Hall, MDJudith A. Smith, B.S., Pharm.D, BCOP, CPHQSpeakers:Julia Canestraro, OD, FAAO Karen Lyle, PA-CKathleen Moore, MDSound engineered and produced by Betheon Whyte on behalf of the Society of Gynecologic Oncology.